* Not logged in   Login :: Register :: Home  RSS Feeds :: Classifieds Contact Us :: About :: Help

All Categories Stock Market News  (Sub Categories)   By Industry    By Company Name    By Ticker  Your Ad Here Your Ad Here (No Feeds) Your Ad Here SHARE Market Report -- In Play (ALNY) (MSN Money) Alnylam Pharma and collaborators present new pre-clinical research on RNAi therapeutics targeting PCSK9 Co announced the presentation of new pre-clinical data from its hypercholesterolemia program, 2010 03 15 07:01 Update update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 4261 failed: 1142 [UPDATE command denied to user '334187_hdlns_ms5'@'10.187.248.89' for table 'feed'] in [update feed set failed_fetches=0, fetched=current_timestamp() where feed_id = 4261] updated 4261 (ALNY (Alnylam Pharmaceuticals Inc)), inserted 0, updated 0, at 2012-05-28 21:11:12 Articles from: ALNY (Alnylam Pharmaceuticals Inc) (MSN Money)   ... More from Category: Stock Market News / By Industry / Consumer Non cyclical / Pharmaceuticals / Therapeutics ... More from Category: Stock Market News / By Company Name / A ... More from Category: Stock Market News / By Ticker / A Previous Page - Next Page   Alnylam Receives Positive Opinion for Orphan Drug Designation from European (more) 2011 02 03 Time to Buy Into Stem Cells? (more) 2011 01 31 Alnylam Receives Positive Opinion for Orphan Drug Designation from European (more) 2011 01 25 Market Report -- In Play (ALNY) (more) 2011 01 25 AstraZeneca Setback on RSV Drug May Spur Deals (more) 2011 01 09 Layoffs Mount in 2010: What Does It Mean for 2011? (more) 2011 01 06 Alnylam Launches 'Alnylam 5x15' Product Strategy and Provides Guidance and (more) 2011 01 06 Alnylam to Webcast Presentation at the 29th Annual J.P. Morgan Healthcare C (more) 2011 01 05 Regulus Therapeutics Promotes Garry E. Menzel, Ph.D., to Chief Operating Of (more) 2011 01 05 Market Report -- In Play (ALNY) (more) 2011 01 05 Market Report -- In Play (ALNY) (more) 2011 01 04 Alnylam Demonstrates RNAi in Man with Systemically Delivered RNAi Therapeut (more) 2011 01 04 Alnylam Presents New Data on Delivery of RNAi Therapeutics and Human Transl (more) 2010 12 16 Market Report -- In Play (ALNY) (more) 2010 12 16 U.S. Stock Options With Biggest Changes in Implied Volatility (more) 2010 12 15 Alnylam Elects Marsha Fanucci to its Board of Directors (more) 2010 12 09 Alnylam to Webcast Presentation at 2010 Deutsche Bank BioFEST (more) 2010 12 08 Market Report -- In Play (ALNY) (more) 2010 12 02 Alnylam's Tuschl II Patent Fully Upheld in European Opposition Proceedings (more) 2010 12 02 Regulus Therapeutics Strengthens Immunology Leadership Team with New Key Ap (more) 2010 12 02 November's Best- and Worst-Performing Biotech Stocks (more) 2010 12 01 RNAi Is On Sale (more) 2010 11 30 Alnylam to Webcast Presentation at Piper Jaffray 22nd Annual Healthcare Con (more) 2010 11 23 Biotech Sector Weekly Rewind (more) 2010 11 20 Alnylam Pharmaceuticals Shares Plunged: What You Need to Know (more) 2010 11 18 Alnylam Biotherapeutics Presents Data on New Applications of RNAi Technolog (more) 2010 11 18 Market Report -- In Play (ALNY) (more) 2010 11 17 Alnylam Comments on Recent Roche Restructuring and Implications for RNAi Th (more) 2010 11 17 Alnylam to Webcast Presentation at Lazard Capital Markets 7th Annual Health (more) 2010 11 11 Zacks Analyst Blog Highlights: Alnylam Pharmaceuticals, Roche, Novartis, Cu (more) 2010 11 11 Market Report -- In Play (ALNY) (more) 2010 11 10 Alnylam Presents Additional Interim Phase I Data for ALN-VSP, an RNAi Thera (more) 2010 11 10 Alnylam Grants New InterfeRxTM Intellectual Property License to Tekmira for (more) 2010 11 04 Alnylam Pharmaceuticals Reports Third Quarter 2010 Financial Results (more) 2010 11 03 Regulus Therapeutics Receives Federal Grant Awards for microRNA Therapeutic (more) 2010 11 03 Alnylam, Medtronic, and CHDI Foundation Form Collaboration to Advance RNAi (more) 2010 11 03 Alnylam Scientists to Present New Data on RNAi Therapeutics at the 61st Ann (more) 2010 10 31 Sanofi-Aventis Completes $10 Million Equity Investment in Regulus Therapeut (more) 2010 10 28 Alnylam to Webcast Conference Call Discussing Third Quarter 2010 Financial (more) 2010 10 27 The War on Cancer: A Long and Ongoing Struggle (more) 2010 10 25 Market Report -- In Play (ALNY) (more) 2010 10 21 Alnylam Seeks to Prove Skeptics Wrong (more) 2010 10 21 Alnylam Seeks to Prove Skeptics Wrong (more) 2010 10 21 Regulus Therapeutics Presented New Advancements in microRNA Therapeutics at (more) 2010 10 21 Biotech Sector Weekly Rewind (more) 2010 10 09 September's Worst Biotech Stocks (more) 2010 10 08 Market Report -- In Play (ALNY) (more) 2010 10 08 Alnylam Scientists Present New Research on Expanded Delivery of RNAi Therap (more) 2010 10 08 Careful What You Wish For, Stem Cell Investors (more) 2010 09 29 Alnylam Publishes Results from Phase IIa Study of ALN-RSV01 in the Treatmen (more) 2010 09 29 Previous Page - Next Page   Your Ad Here

HDLNS (dot com) - News Headlines Updated 24 Hours a Day. "HDLNS (dot com)" is a trademark of Avant Garde Creatives, Inc. This site, its design, and all associated software © 2005, Avant Garde Creatives, Inc. All rights reserved. All content is provided for your personal, non-commercial use, in accordance with the terms of its providers. HDLNS (dot com) is search engine sitemap friendly. Classifieds